ASF1B silencing inhibits the growth and cell cycle arrest, induces apoptosis, and reduces the expression levels of PCNA, cyclinB1, cyclinE2, and CDK9 in HCC cells (28). Here, PCNA is linked to hepatocellular carcinoma.